Evidence map›Paper›PMID 33242649›Full record

ArticleMetabolic engineering2021

Metabolic engineering of tomato fruit enriched in L-DOPA.

Dario Breitel, Paul Brett, Saleh Alseekh, Alisdair R Fernie, Eugenio Butelli, Cathie Martin

Open access · hybridAbstract read
In one paragraph

Article in Metabolic engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Spatio-temporal expression of polyphenol oxidase unveils the dynamics of L-DOPA accumulation in faba bean (Physiology and molecular biology of plants : an international journal of functional plant biology · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Dario BreitelDepartment of Metabolic Biology and Biological Chemistry, The John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK; Tropic Biosciences, Innovation Centre, Norwich Research Park, NR4 7GJ, UK.
Paul BrettDepartment of Metabolic Biology and Biological Chemistry, The John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK.
Saleh AlseekhMax-Planck-Institut Fur Molekulare Pflanzenphysiologie, Am Muhlenberg 1, 14476, Potsdam-Golm, Germany.
Alisdair R FernieMax-Planck-Institut Fur Molekulare Pflanzenphysiologie, Am Muhlenberg 1, 14476, Potsdam-Golm, Germany.
Eugenio ButelliDepartment of Metabolic Biology and Biological Chemistry, The John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK.
Cathie MartinDepartment of Metabolic Biology and Biological Chemistry, The John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK. Electronic address: cathie.martin@jic.ac.uk.
John Innes Centre · GBMax Planck Institute of Molecular Plant Physiology · DE

Funding

Biotechnology and Biological Sciences Research Council BB/J004596/1Biotechnology and Biological Sciences Research Council BB/P012523/1Biotechnology and Biological Sciences Research Council BBS/E/J/000PR9790
6 · The paper itself

Abstract

L-DOPA, also known as Levodopa or L-3,4-dihydroxyphenylalanine, is a non-standard amino acid, and the gold standard drug for the treatment for Parkinson's Disease (PD). Recently, a gene encoding the enzyme that is responsible for its synthesis, as a precursor of the coloured pigment group betalains, was identified in beetroot, BvCYP76AD6. We have engineered tomato fruit enriched in L-DOPA through overexpression of BvCYP76AD6 in a fruit specific manner. Analysis of the transgenic fruit revealed the feasibility of accumulating L-DOPA in a non-naturally betalain-producing plant. Fruit accumulating L-DOPA also showed major effects on the fruit metabolome. Some of these changes included elevation of amino acids levels, changes in the levels of intermediates of the TCA and glycolysis pathways and reductions in the levels of phenolic compounds and nitrogen-containing specialised metabolites. Furthermore, we were able to increase the L-DOPA levels further by elevating the expression of the metabolic master regulator, MYB12, specifically in tomato fruit, together with BvCYP76AD6. Our study elucidated new roles for L-DOPA in plants, because it impacted fruit quality parameters including antioxidant capacity and firmness. The L-DOPA levels achieved in tomato fruit were comparable to the levels in other non-seed organs of L-DOPA - accumulating plants, offering an opportunity to develop new biological sources of L-DOPA by widening the repertoire of L-DOPA-accumulating plants. These tomato fruit could be used as an alternative source of this important pharmaceutical.

Indexed as

LevodopaSolanum lycopersicumBetalainsFruitMetabolic EngineeringBetalainsLevodopaL-DOPAMelaninMYB12Shelf-lifeTomato

Identifiers

PMID33242649
PMCPMC8054910
OpenAlexW3107584250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.